Enhancing shareholder value through exceptional business performance and practices, and through responsible and effective communication with its shareholders.
Dr. Mark Poznansky provided shareholders with an overview and update on VaxCelerate, a potential vaccine for COVID-19 and answered pre-submitted questions.